Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies

Neoadjuvant therapy for breast cancer

(2010) Stephen V. Liu et al.   JOURNAL OF SURGICAL ONCOLOGY

Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ

(2009) Yunn-Yi Chen et al.   BMC CANCER

Neoadjuvant endocrine treatment in primary breast cancer – Review of literature

(2009) J. Mathew et al.   BREAST

A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer

(2009) O. C. Freedman et al.   BREAST CANCER RESEARCH AND TREATMENT

Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer

(2009) Robin L. Jones et al.   BREAST CANCER RESEARCH AND TREATMENT

Histopathological criteria and selection algorithms for BRCA1 genetic testing

(2009) Dorothea Gadzicki et al.   CANCER GENETICS AND CYTOGENETICS

Cell cycle alterations and their relationship to proliferation in apocrine adenosis of the breast

(2009) Ghada Elayat et al.   HISTOPATHOLOGY

Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer

(2009) José Baselga et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical, pathological, proliferative and molecular responses associated with neoadjuvant aromatase inhibitor treatment in breast cancer

(2009) W.R. Miller   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer

(2009) Jennifer Specht et al.   SEMINARS IN RADIATION ONCOLOGY

The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer

(2008) Robin L. Jones et al.   BREAST CANCER RESEARCH AND TREATMENT

Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer

(2008) A. Rody et al.   BREAST CANCER RESEARCH AND TREATMENT

Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity

(2008) R Torrisi et al.   BRITISH JOURNAL OF CANCER

Molecular Grading of Ductal Carcinoma In situ of the Breast

(2008) R. L. Balleine et al.   CLINICAL CANCER RESEARCH

Emerging Biomarkers and New Understanding of Traditional Markers in Personalized Therapy for Breast Cancer

(2008) M. Dowsett et al.   CLINICAL CANCER RESEARCH

Prognostic relevance of glucosylceramide synthase (GCS) expression in breast cancer

(2008) Eugen Ruckhäberle et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Research Issues Affecting Preoperative Systemic Therapy for Operable Breast Cancer

(2008) Antonio C. Wolff et al.   JOURNAL OF CLINICAL ONCOLOGY

Type 1 Receptor Tyrosine Kinase Profiles Identify Patients With Enhanced Benefit From Anthracyclines in the BR9601 Adjuvant Breast Cancer Chemotherapy Trial

(2008) John M.S. Bartlett et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole

(2008) Giuseppe Viale et al.   JOURNAL OF CLINICAL ONCOLOGY